a month ago
JAZZ
AnalystsAndrea NewkirkAndrea Newkirk's Stock Forecasts
AnalystsAndrea Newkirk
Analyst Ranking
Top 24%
#1294 out of 5550 analysts
Average Return
+58.93%
Win Rate
25%3 out of 12
Risk vs Reward
Poor
Good
Andrea Newkirk's 5 best and worst ratings
Andrea Newkirk Analyst Color
Get additional color on Andrea Newkirk's coverage of popular stocks
Andrea Newkirk's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sagimet Biosciences IncSGMT | 1 | Strong Sell | $7.00 | -29.44% | Reinstates | a month ago |
Iovance Biotherapeutics IncIOVA | 1 | Strong Buy | $15.00 | +76.89% | Reinstates | a month ago |
Meiragtx Holdings PLCMGTX | 1 | Hold | $16.00 | +68.60% | Initiates Coverage On | a month ago |
United Therapeutics CorpUTHR | 1 | Strong Sell | $321.00 | -46.39% | Initiates Coverage On | a month ago |
Insmed IncINSM | 1 | Strong Buy | $188.00 | +66.99% | Reinstates | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Buy | $337.00 | +56.03% | Reinstates | a month ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $441.00 | +32.72% | Reinstates | a month ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Strong Buy | $704.00 | +63.58% | Reinstates | a month ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $267.00 | +39.56% | Reinstates | a month ago |
Tarsus Pharmaceuticals IncTARS | 1 | Strong Buy | $116.00 | +54.98% | Reinstates | a month ago |
Abcellera Biologics IncABCL | 1 | Hold | $13.00 | +5.95% | Reinstates | a month ago |
Alkermes PLCALKS | 2 | Hold | $50.00 | +10.28% | Reinstates | a month ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Hold | $74.00 | +23.54% | Reinstates | a month ago |
Kodiak Sciences IncKOD | 1 | Hold | $36.00 | -63.70% | Reinstates | a month ago |
Schrodinger IncSDGR | 1 | Hold | $19.00 | N/A | Initiates Coverage On | a year ago |
89bio IncETNB | 1 | Hold | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.